These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1833597)

  • 21. Accumulation of CD16-CD56+ natural killer cells with high affinity interleukin 2 receptors in human early pregnancy decidua.
    Nishikawa K; Saito S; Morii T; Hamada K; Ako H; Narita N; Ichijo M; Kurahayashi M; Sugamura K
    Int Immunol; 1991 Aug; 3(8):743-50. PubMed ID: 1716974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multifunctional human CD56 low CD16 low natural killer cells are the prominent subset in bone marrow of both healthy pediatric donors and leukemic patients.
    Stabile H; Nisti P; Morrone S; Pagliara D; Bertaina A; Locatelli F; Santoni A; Gismondi A
    Haematologica; 2015 Apr; 100(4):489-98. PubMed ID: 25596273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cord blood stem cell derived CD16
    Valipour B; Abedelahi A; Naderali E; Velaei K; Movassaghpour A; Talebi M; Montazersaheb S; Karimipour M; Darabi M; Chavoshi H; Nozad Charoudeh H
    Life Sci; 2020 Feb; 242():117223. PubMed ID: 31881222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Redistribution of natural killer (NK) cell frequency and NK cytotoxic activity in primary IgA nephropathy.
    Antonaci S; Polignano A; Ottolenghi A; Tortorella C; Schena FP
    Cytobios; 1992; 69(276):27-34. PubMed ID: 1374697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of a lipid-like cytotoxin from human CD16+ natural killer cells.
    Cosentino LM; Cathcart MK
    Cancer Res; 1989 Dec; 49(23):6662-9. PubMed ID: 2531033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of lymphocyte surface markers in childhood acute lymphoblastic leukemia during maintenance chemotherapy].
    Sugita K; Kurosawa H; Sakakibara H; Eguchi M; Furukawa T
    Gan To Kagaku Ryoho; 1992 May; 19(5):659-64. PubMed ID: 1580639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo.
    Nagler A; Lanier LL; Phillips JH
    J Exp Med; 1990 May; 171(5):1527-33. PubMed ID: 2139697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor.
    Levitt LJ; Nagler A; Lee F; Abrams J; Shatsky M; Thompson D
    J Clin Invest; 1991 Jul; 88(1):67-75. PubMed ID: 1676038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.
    Lanier LL; Le AM; Civin CI; Loken MR; Phillips JH
    J Immunol; 1986 Jun; 136(12):4480-6. PubMed ID: 3086432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new strategy for treating patients with CD7+, CD4-, CD8- acute lymphoblastic leukaemia.
    Ono K; Yoshida T; Tsuchiya K; Nakazato S; Nagumo F; Shimamoto Y
    Eur J Haematol; 1997 Feb; 58(2):130-2. PubMed ID: 9111597
    [No Abstract]   [Full Text] [Related]  

  • 31. Characterization of the Fc mu receptor on human natural killer cells. Interaction with its physiologic ligand, human normal IgM, specificity of binding, and functional effects.
    Pricop L; Rabinowich H; Morel PA; Sulica A; Whiteside TL; Herberman RB
    J Immunol; 1993 Sep; 151(6):3018-29. PubMed ID: 7690792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic switch from CD45RA+ to CD45RA- by normal blood T cells is associated with increased HLA-ABC expression for CD4+ and CD8+ populations but not for the NK-associated CD4-CD8dim+ or CD4-CD8- fractions.
    Jones RA; Richards SJ; Roberts BE; Child JA; Scott CS
    Immunology; 1990 May; 70(1):55-60. PubMed ID: 1972374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective alterations in natural killer cell subsets in patients with atopic dermatitis.
    Wehrmann W; Reinhold U; Kukel S; Franke N; Uerlich M; Kreysel HW
    Int Arch Allergy Appl Immunol; 1990; 92(3):318-22. PubMed ID: 1703517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD16+ NK cells decrease in all stages of HIV infection through a selective depletion of the CD16+CD8+CD3- subset.
    Mansour I; Doinel C; Rouger P
    AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1451-7. PubMed ID: 2150319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased numbers of CD4+ T lymphocytes in peripheral blood after treatment of childhood acute lymphoblastic leukemia.
    Mazur B; Szczepański T; Karpe J; Sońta-Jakimczyk D; Bubała H; Torbus M
    Leuk Res; 2006 Jan; 30(1):33-6. PubMed ID: 16039713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-induced expression of Fc gamma RIII (CD16) on human monocytes.
    Phillips JH; Chang CW; Lanier LL
    Eur J Immunol; 1991 Apr; 21(4):895-9. PubMed ID: 1826887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between radical production and natural killer cytotoxic factor (NKCF) in canine natural killer (NK) cell-mediated cytotoxicity.
    Nakada Y; Tsukatani Y; Kosaka T; Kuwabara M; Tanaka S; Fujiwara K
    Vet Immunol Immunopathol; 1997 Mar; 55(4):273-82. PubMed ID: 9151399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen).
    Lanier LL; Kipps TJ; Phillips JH
    J Exp Med; 1985 Dec; 162(6):2089-106. PubMed ID: 2415663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of cloned human natural killer cells via Fc gamma RIII.
    Werfel T; Uciechowski P; Tetteroo PA; Kurrle R; Deicher H; Schmidt RE
    J Immunol; 1989 Feb; 142(4):1102-6. PubMed ID: 2464637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.